Amarantus BioScience Holdings, Inc. (AMBS)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: May 29, 2026
AMBS Market Cap
AMBS has a market cap or net worth of $630 as of June 3, 2026. Its market cap has decreased by -99.83% in one year.
Market Cap
630.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 14, 2011, AMBS's market cap has decreased from 100.50M to 630.00, a decrease of -100.00%. That is a compound annual growth rate of -55.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 630.00 | - |
| Dec 30, 2025 | 630.00 | - |
| Dec 31, 2024 | 630.00 | -99.80% |
| Dec 29, 2023 | 315.20K | -68.01% |
| Dec 30, 2022 | 985.33K | -87.08% |
| Dec 31, 2021 | 7.63M | 165.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| TetraLogic Pharmaceuticals | 973.00 |
| Trevena | 959.00 |
| RegeneRx Biopharmaceuticals | 905.00 |
| Alzex Neuropharma | 753.00 |
| Pathfinder Cell Therapy | 667.00 |
| Proteonomix | 633.00 |